Toggle navigation
Home
Search
Services
Blog
Contact
About
Clin Trials & Clin Markers for Immunologic Diseases-266005411
Brigham and Women's Hospital, Boston, MA, United States
Search grants from Brigham and Women's Hospital
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Understanding Variation in Treatment Intensity with Lower Extremity PAD
Regulation of Glucose Metabolism by Skeletal Muscle Nuclear Receptor 4A
Early Onset Schizophrenia;Neuroimaging Studies
CI-TEAM Implementation Project: Cyberinfrastructure for Quality Understanding and Engagement for Students and Teachers (CyberQUEST)
Partial Travel Support for US Students Attending the MEMS 2000 Conference
Recently added grants:
Beta Cell Intracellular Calcium and Diabetes
TIM-1 and AhR: Key regulators of B-cell mediated Transplant Tolerance
Molecular and Metabolic inter-kingdom actions of a bacterial quorum sensing signal in promotion of host tolerance/resilience.
The Functional Role of GRM3 in Colon Cancer
p190 RhoGAP signaling in epithelial oncogenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI005411-001
Application #
6688689
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 2002
N01 AI
Clin Trials & Clin Markers for Immunologic Diseases-266005411
/ Brigham and Women's Hospital
NIH 2000
N01 AI
Clin Trials & Clin Markers for Immunologic Diseases
Weiner, Howard L. / Brigham and Women's Hospital
$646,654
Publications
Kivisakk, P; Healy, B C; Viglietta, V et al.
(2009)
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.
Neurology 72:1922-30
Comments
Be the first to comment on this grant